# Risk Allele rs117026326-Mediated Alternative Splicing of GTF2I Promotes B Cell Proliferation in Primary Sjögren's Syndrome

**Authors:** Chaowen Luo, Chaofeng Lian, Jinlei Sun, Liling Zhao, Shuo Zhang, Yongzhe Li, Hua Chen, Fengchun Zhang

PMC · DOI: 10.1155/jimr/4821639 · Journal of Immunology Research · 2025-02-18

## TL;DR

A genetic variant linked to Sjögren's syndrome causes alternative splicing of a gene, leading to increased B cell activity through a specific protein interaction.

## Contribution

Identifies a risk allele that modulates GTF2I splicing to promote B cell proliferation in primary Sjögren's syndrome.

## Key findings

- Risk allele rs117026326 increases GTF2IΔ and GTF2Iζ isoform expression in pSS patients.
- GTF2IΔ promotes B cell proliferation and upregulates c-FOS expression.
- c-FOS inhibition reverses GTF2IΔ-driven B cell proliferation.

## Abstract

Objectives: Primary Sjögren's syndrome (pSS) is associated with a risk allele T of rs117026326 located at a potential splicing enhancer within the intronic region of general transcription factor II-I (GTF2I). This study aimed to explore the rs117026326-regulated alternative splicing of GTF2I and its role in B cell overactivation in pSS.

Methods: GTF2I isoform expressions and rs117026326 genotypes of pSS peripheral blood mononuclear cells (PBMCs) were examined using quantitative PCR and Sanger sequencing, respectively. GTF2IΔ was overexpressed in B cells, T cells, and macrophages using plasmid transfection. Proliferation of B cells and T cells was determined using Cell Counting Kit-8 (CCK8) assay. CD4+ T cell differentiation was inspected using flow cytometry. Proinflammatory cytokine production of macrophages was investigated using quantitative PCR. c-FOS expression in GTF2IΔ-transfected B cells was tested by quantitative PCR, and proliferation of GTF2IΔ-transfected B cells treated with c-FOS siRNA or c-FOS inhibitor was interrogated using CCK8 assay.

Results: pSS patients with risk allele of rs117026326 expressed higher levels of GTF2IΔ and GTF2Iζ isoforms. GTF2IΔ expression was correlated with serum immunoglobulin G (IgG). GTF2IΔ promoted B cell proliferation and upregulated c-FOS expression. Knocking down or inhibition of c-FOS reversed B cell proliferation driven by GTF2IΔ.

Conclusion: pSS risk allele of rs117026326 modulates alternative splicing of GTF2I and upregulates GTF2IΔ isoform, which promotes B cell proliferation through enhancing binding and transcription of c-FOS.

## Linked entities

- **Genes:** GTF2I (general transcription factor IIi) [NCBI Gene 2969], FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353]

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, GTF2I (general transcription factor IIi) [NCBI Gene 2969] {aka BAP135, BTKAP1, DIWS, GTFII-I, IB291, SPIN}
- **Diseases:** Primary Sjogren's Syndrome (MESH:D012859)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs117026326

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11858827/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11858827/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC11858827/full.md

---
Source: https://tomesphere.com/paper/PMC11858827